IP Library Granted Patent US 6,942,986
Granted Patent B2
US 6,942,986 · App. 09/961,452 · Granted Sep 13, 2005

Compositions and methods for regulating bacterial pathogenesis

Assignees: Princeton University; University Technologies International
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,942,986
App. No.
09/961,452
Granted
Sep 13, 2005
Kind
B2
Abstract

The production of a purified extracellular bacterial signal called autoinducer-2 is regulated by changes in environmental conditions associated with a shift from a free-living existence to a colonizing or pathogenic existence in a host organism. Autoinducer-2 stimulates LuxQ luminescence genes, and is believed also to stimulate a variety of pathogenesis related genes in the bacterial species that produce it. A new class of bacterial genes is involved in the biosynthesis of autoinducer-2.

Claims (7)

1. A method for detecting an autoinducer, selected from the group consisting of 4,5-dihidroxy-2,3-pentanedione (AI-2) and an analog thereof capable of interacting with Vibrio haveyi LuxP or LuxQ protein and thereby inducing Vibrio harveyi luminescence, in a sample comprising:

a) contacting the sample with a bacterial cell capable of producing a detectable amount of light in response to the autoinducer, wherein the bacterial cell comprises a first alteration in a sensor gene locus that inhibits detection of a first autoindecuer and a second alteration in a biosynthetic gene locus that inhibits production of 4,5-dihidroxy-2,3-pentanedione (AI-2) or an analog thereof capable of interacting with Vibrio harveyi LuxP or LuxQ protein and thereby inducing Vibrio harveyi luminescence; and

b) detecting light produced by the bacterial cell, thereby detecting an exogenous autoinducer in the sample.

2. The method of claim 1 , wherein the first alteration inhibits detection of (N-(3-hydroxybutanoyl)-L-homoserine lactone) (AI-1).

3. The method of claim 2 , wherein the first bacterial cell is luxN − .

4. The method of claim 3 , wherein the bacterial cell is luxS − .

5. The method of claim 4 , wherein the bacterial cell is V. harveyi strain MM32 (ATCC access No. BAA-1121.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 12, 2016
From: PRINCETON UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 038689/0108 →
Continuity (3)
Division 0945397600 · Dec 2, 1999
Provisional Application 6011057000 · Dec 2, 1998
Related Publication 20020072052A1 · Jun 13, 2002